BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18627596)

  • 21. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
    Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
    PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
    Tanton H; Sewastianik T; Seo HS; Remillard D; Pierre RS; Bala P; Aitymbayev D; Dennis P; Adler K; Geffken E; Yeoh Z; Vangos N; Garbicz F; Scott D; Sethi N; Bradner J; Dhe-Paganon S; Carrasco RD
    Sci Adv; 2022 Apr; 8(17):eabm3108. PubMed ID: 35486727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.
    Jiang M; Kang Y; Sewastianik T; Wang J; Tanton H; Alder K; Dennis P; Xin Y; Wang Z; Liu R; Zhang M; Huang Y; Loda M; Srivastava A; Chen R; Liu M; Carrasco RD
    Nat Commun; 2020 Jan; 11(1):19. PubMed ID: 31911584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.
    Sierra J; Yoshida T; Joazeiro CA; Jones KA
    Genes Dev; 2006 Mar; 20(5):586-600. PubMed ID: 16510874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of Wnt/β-catenin pathway dependency in colorectal cancer.
    Scholer-Dahirel A; McLaughlin ME
    Cell Cycle; 2012 Jan; 11(1):9-10. PubMed ID: 22157091
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypoxia-inducible factor 1α induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/β-catenin transcriptional cofactor BCL9.
    Orikasa S; Kawashima N; Tazawa K; Hashimoto K; Sunada-Nara K; Noda S; Fujii M; Akiyama T; Okiji T
    Sci Rep; 2022 Jan; 12(1):682. PubMed ID: 35027586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
    Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
    PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
    El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
    Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
    Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
    DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.
    Lavergne E; Hendaoui I; Coulouarn C; Ribault C; Leseur J; Eliat PA; Mebarki S; Corlu A; Clément B; Musso O
    Oncogene; 2011 Jan; 30(4):423-33. PubMed ID: 20856206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
    Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
    Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.
    Xu W; Zhou W; Cheng M; Wang J; Liu Z; He S; Luo X; Huang W; Chen T; Yan W; Xiao J
    Sci Rep; 2017 Jan; 7():40446. PubMed ID: 28074862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.